Can erythropoietin therapy improve survival?
Glaspy J, Dunst J
Oncology 2004;67 Suppl 1:5-11.
Review by
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.
Rao SV, Jollis JG, Harrington RA, et al.
JAMA 2004;292(13):1555-1562.
Review by M. Contreras, V. Kretschmer
A comparison of albumin and saline for fluid resuscitation in the intensive care unit.
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators
N Engl J Med 2004;350(22):2247-2256.
Review by
The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery.
Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF, Stafford-Smith M
Ann Thorac Surg 2003;76(3):784-791.
Review by
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.
Henke M, Laszig R, Rube C, et al.
Lancet 2003;362:1255-1260.
Review by
Acute normovolemic hemodilution and intraoperative cell salvage in aortic surgery.
Torella F, Haynes SL, Kirwan CC, Bhatt AN, McCollum CN
J Vasc Surg 2002;36(1):31-34.
Review by Van der Linden P
Effect of blood transfusion on long-term survival after cardiac operation.
Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ
Ann Thorac Surg 2002;74(4):1180-1186.
Review by Hardy JF
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659